HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 48186,
"recordsTotal": 48186,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=completion_date&start=44400",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=completion_date&start=43800",
"results": [
{
"registry_id": "NCT06554717",
"publication_url": "https://clinicaltrials.gov/study/NCT06554717",
"title": "Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV",
"has_exemption": false,
"start_date": "2025-07-07",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06901687",
"publication_url": "https://clinicaltrials.gov/study/NCT06901687",
"title": "Home-Based tDCS for Depression in Multiple Sclerosis: A Randomized Sham-Controlled Trial",
"has_exemption": false,
"start_date": "2025-08-11",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07049848",
"publication_url": "https://clinicaltrials.gov/study/NCT07049848",
"title": "SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma",
"has_exemption": false,
"start_date": "2025-09-11",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07102381",
"publication_url": "https://clinicaltrials.gov/study/NCT07102381",
"title": "A Phase 2, Randomized, Multicenter, Open-label Neoadjuvant Study Evaluating Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer",
"has_exemption": false,
"start_date": "2025-09-24",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jazz Pharmaceuticals",
"sponsor_slug": "jazz-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06885554",
"publication_url": "https://clinicaltrials.gov/study/NCT06885554",
"title": "Adjustment Disorders in the US Military: Disease Trajectories and ADNM-20-Mil Validation",
"has_exemption": false,
"start_date": "2025-10-06",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Henry M. Jackson Foundation for the Advancement of Military Medicine",
"sponsor_slug": "henry-m-jackson-foundation-for-the-advancement-of-military-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07108387",
"publication_url": "https://clinicaltrials.gov/study/NCT07108387",
"title": "A Randomized Study of Tocilizumab Discontinuation for Patients With Giant Cell Arteritis in Remission (AGA01)",
"has_exemption": false,
"start_date": "2025-12-11",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07146685",
"publication_url": "https://clinicaltrials.gov/study/NCT07146685",
"title": "Effect of Local Anesthetic Concentration on Rebound Pain: A Randomized Control Study",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07457489",
"publication_url": "https://clinicaltrials.gov/study/NCT07457489",
"title": "Vanderbilt Integrated Community TMS for Opioid Recovery",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06707493",
"publication_url": "https://clinicaltrials.gov/study/NCT06707493",
"title": "A Randomized, Placebo-Controlled Phase 2 Study of IDH1 Inhibition Using Ivosidenib as Maintenance Therapy for IDH1-mutant Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07158021",
"publication_url": "https://clinicaltrials.gov/study/NCT07158021",
"title": "Phase 2 Randomized Trial to Examine Ovarian Function Suppression for Breast Cancer (OFS)",
"has_exemption": false,
"start_date": "2026-01-22",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06654193",
"publication_url": "https://clinicaltrials.gov/study/NCT06654193",
"title": "Allogeneic Adipose-derived Mesenchymal Stem Cells (MSC) for Acute Kidney Injury After Trauma or Burn",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hope Biosciences LLC",
"sponsor_slug": "hope-biosciences-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07246993",
"publication_url": "https://clinicaltrials.gov/study/NCT07246993",
"title": "Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms: A Trial of tDCS and Cognitive Training 3-12 Months Post-mTBI",
"has_exemption": false,
"start_date": "2026-03-05",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216690",
"publication_url": "https://clinicaltrials.gov/study/NCT07216690",
"title": "Pregnenolone as a Treatment for Cannabis Intoxication",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07313826",
"publication_url": "https://clinicaltrials.gov/study/NCT07313826",
"title": "Neurolumen for Chronic Lower Back Pain: A Pilot RCT Study",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Defense and Veterans Center for Integrative Pain Management",
"sponsor_slug": "defense-and-veterans-center-for-integrative-pain-management",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07180615",
"publication_url": "https://clinicaltrials.gov/study/NCT07180615",
"title": "Neomycine/Metronidazole- vs Rifaximin-based Gut Decolonisation Prior to Colon Surgery: a Randomized Multicenter Trial",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Universität Luzern",
"sponsor_slug": "universitat-luzern",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07459829",
"publication_url": "https://clinicaltrials.gov/study/NCT07459829",
"title": "A Phase 2b, Randomized, Double-masked, Parallel-group, Multi-center Study to Evaluate the Efficacy and Safety of CU06-1004 for 24 Weeks in Patients With Center-Involved Diabetic Macular Edema (DME)",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Curacle Co., Ltd.",
"sponsor_slug": "curacle-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03867487",
"publication_url": "https://clinicaltrials.gov/study/NCT03867487",
"title": "SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease",
"has_exemption": false,
"start_date": "2027-05-01",
"completion_date": "2028-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Justin Ryder",
"sponsor_slug": "justin-ryder",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06183268",
"publication_url": "https://clinicaltrials.gov/study/NCT06183268",
"title": "Evaluation of Radiobiological Effects in Skin Toxicities for Head and Neck Cancer Patients With Pencil Beam Scanning Proton Therapy",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2028-01-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Covenant Health Cancer Center",
"sponsor_slug": "covenant-health-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06207305",
"publication_url": "https://clinicaltrials.gov/study/NCT06207305",
"title": "A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma",
"has_exemption": false,
"start_date": "2024-01-30",
"completion_date": "2028-01-02",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07063212",
"publication_url": "https://clinicaltrials.gov/study/NCT07063212",
"title": "A Phase II Study of Sacituzumab Govitecan in Combination With Cetuximab in Patients With Recurrent Metastatic HNSCC That Has Progressed After First-Line Therapy",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2028-01-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07172919",
"publication_url": "https://clinicaltrials.gov/study/NCT07172919",
"title": "A Rollover Study of Sotorasib With or Without Panitumumab for the Treatment of Cancer Subjects With KRAS p.G12C Mutation Previously Treated in an Amgen-Sponsored Study",
"has_exemption": false,
"start_date": "2026-01-02",
"completion_date": "2028-01-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06732388",
"publication_url": "https://clinicaltrials.gov/study/NCT06732388",
"title": "Repurposing Itraconazole for Secondary Prevention of Metaplasia and Primary Prevention of Cancer in Patients With High-Risk Barrett's Esophagus in Combination With Ablation",
"has_exemption": false,
"start_date": "2026-02-16",
"completion_date": "2028-01-02",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03625648",
"publication_url": "https://clinicaltrials.gov/study/NCT03625648",
"title": "CSP #2008 - Pentoxifylline in Diabetic Kidney Disease",
"has_exemption": false,
"start_date": "2019-11-18",
"completion_date": "2028-01-03",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06891417",
"publication_url": "https://clinicaltrials.gov/study/NCT06891417",
"title": "A Phase 1/2, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Immunogenicity, and Efficacy of a Chlamydia Trachomatis mRNA Vaccine Candidate in Adults Aged 18 to 29 Years",
"has_exemption": false,
"start_date": "2025-03-27",
"completion_date": "2028-01-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325253",
"publication_url": "https://clinicaltrials.gov/study/NCT07325253",
"title": "A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations",
"has_exemption": false,
"start_date": "2025-11-18",
"completion_date": "2028-01-03",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05733000",
"publication_url": "https://clinicaltrials.gov/study/NCT05733000",
"title": "Phase II Open-Label Multi-Cohort Study Evaluating CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Patients With Advanced Chemorefractory Colorectal, Pancreatic, or Other Solid Cancers",
"has_exemption": false,
"start_date": "2023-03-08",
"completion_date": "2028-01-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06659640",
"publication_url": "https://clinicaltrials.gov/study/NCT06659640",
"title": "A Phase 1/2, Randomized, Double-blind, Placebo-controlled, 2-part Study of the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Dose ALN-6400 in Adult Healthy Volunteers and Multiple Dose ALN-6400 in Adult Patients With Hereditary Hemorrhagic Telangiectasia (HHT)",
"has_exemption": false,
"start_date": "2024-11-07",
"completion_date": "2028-01-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Alnylam Pharmaceuticals",
"sponsor_slug": "alnylam-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07324070",
"publication_url": "https://clinicaltrials.gov/study/NCT07324070",
"title": "New Methods Electroconvulsive Therapy Augmentation",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2028-01-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Charles University, Czech Republic",
"sponsor_slug": "charles-university-czech-republic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05797168",
"publication_url": "https://clinicaltrials.gov/study/NCT05797168",
"title": "A Modular Phase I/IIa, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Ascending Doses of AZD5335 Monotherapy and in Combination With Anti-cancer Agents in Participants With Solid Tumors",
"has_exemption": false,
"start_date": "2023-06-05",
"completion_date": "2028-01-06",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07047118",
"publication_url": "https://clinicaltrials.gov/study/NCT07047118",
"title": "A Phase II, Randomized, Open-label, Multi-center Study of JSB462 (Luxdegalutamide) in Combination With Lutetium (177Lu) Vipivotide Tetraxetan in Adult Male Patients With PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC)",
"has_exemption": false,
"start_date": "2025-07-03",
"completion_date": "2028-01-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06731894",
"publication_url": "https://clinicaltrials.gov/study/NCT06731894",
"title": "A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2028-01-07",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06307431",
"publication_url": "https://clinicaltrials.gov/study/NCT06307431",
"title": "A Phase 2, Randomized, Double-blind, Clinical Study of V940 (mRNA-4157) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in the Adjuvant Treatment of Participants With Renal Cell Carcinoma (INTerpath-004).",
"has_exemption": false,
"start_date": "2024-04-10",
"completion_date": "2028-01-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04083183",
"publication_url": "https://clinicaltrials.gov/study/NCT04083183",
"title": "Targeted Astatine-211-Labeled BC8-B10 Monoclonal Antibody as Reduced Intensity Conditioning for Nonmalignant Diseases",
"has_exemption": false,
"start_date": "2020-06-16",
"completion_date": "2028-01-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07015242",
"publication_url": "https://clinicaltrials.gov/study/NCT07015242",
"title": "The CAROLYN Trial: Lisocabtagene Maraleucelas First-Line Therapy for Primary Central Nervous System Lymphoma (PCNSL) in Transplant-Ineligible Patients",
"has_exemption": false,
"start_date": "2025-11-06",
"completion_date": "2028-01-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Juno Therapeutics, Inc., a Bristol-Myers Squibb Company",
"sponsor_slug": "juno-therapeutics-inc-a-bristol-myers-squibb-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04592445",
"publication_url": "https://clinicaltrials.gov/study/NCT04592445",
"title": "Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having Heart Failure With Preserved Ejection Fraction: Randomized Controlled Feasibility Trial - The Rebalance HF Study",
"has_exemption": false,
"start_date": "2020-12-18",
"completion_date": "2028-01-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Axon Therapies, Inc.",
"sponsor_slug": "axon-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06132958",
"publication_url": "https://clinicaltrials.gov/study/NCT06132958",
"title": "A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy (MK-2870-005/ENGOT-en23/GOG-3095)",
"has_exemption": false,
"start_date": "2023-12-06",
"completion_date": "2028-01-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06223568",
"publication_url": "https://clinicaltrials.gov/study/NCT06223568",
"title": "Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer",
"has_exemption": false,
"start_date": "2024-06-10",
"completion_date": "2028-01-10",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06120491",
"publication_url": "https://clinicaltrials.gov/study/NCT06120491",
"title": "A Randomized, 2-cohort, Double-blind, Placebo-controlled, Phase III Study of Saruparib (AZD5305) in Combination With Physician's Choice New Hormonal Agents in Patients With HRRm and Non-HRRm Metastatic Castration-Sensitive Prostate Cancer (EvoPAR-Prostate01)",
"has_exemption": false,
"start_date": "2023-11-21",
"completion_date": "2028-01-11",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318597",
"publication_url": "https://clinicaltrials.gov/study/NCT07318597",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamic Effects of REGN13335, an Anti-PDGF-B Monoclonal Antibody, in Adults With Pulmonary Arterial Hypertension",
"has_exemption": false,
"start_date": "2026-01-29",
"completion_date": "2028-01-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07196748",
"publication_url": "https://clinicaltrials.gov/study/NCT07196748",
"title": "A Phase 3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol in Adults With an Open Label Study in Adolescents to Evaluate the Efficacy and Safety of Induction and Maintenance Therapy With Icotrokinra in Participants With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-01-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03476681",
"publication_url": "https://clinicaltrials.gov/study/NCT03476681",
"title": "Phase 1/2 With Expansion Cohorts in a Study of NEO-201 in Adults With Chemo-Resistant Solid Tumors",
"has_exemption": false,
"start_date": "2019-01-18",
"completion_date": "2028-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Precision Biologics, Inc",
"sponsor_slug": "precision-biologics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05668351",
"publication_url": "https://clinicaltrials.gov/study/NCT05668351",
"title": "Phase II Trial of Sparing the Urethra, Pudendal Artery and Rectum During Stereotactic Ablative Body Radiotherapy (SUPR-SABR) for Low and Intermediate Risk Prostate Cancer",
"has_exemption": false,
"start_date": "2023-05-12",
"completion_date": "2028-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06043674",
"publication_url": "https://clinicaltrials.gov/study/NCT06043674",
"title": "A Phase 2 Study of Glofitamab as Monotherapy or in Combination With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation",
"has_exemption": false,
"start_date": "2024-01-22",
"completion_date": "2028-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Christine Ryan",
"sponsor_slug": "christine-ryan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06194929",
"publication_url": "https://clinicaltrials.gov/study/NCT06194929",
"title": "Phase 1b/2 Trial of Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma",
"has_exemption": false,
"start_date": "2024-03-20",
"completion_date": "2028-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961071",
"publication_url": "https://clinicaltrials.gov/study/NCT06961071",
"title": "Parathyroid Allotransplant for Treatment of Hypoparathyroidism: PATTH",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2028-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Peter Stock",
"sponsor_slug": "peter-stock",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07357389",
"publication_url": "https://clinicaltrials.gov/study/NCT07357389",
"title": "VR for ICU Delirium Prevention",
"has_exemption": false,
"start_date": "2026-03-10",
"completion_date": "2028-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Cedars-Sinai Medical Center",
"sponsor_slug": "cedars-sinai-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07458087",
"publication_url": "https://clinicaltrials.gov/study/NCT07458087",
"title": "Feasibility and Accuracy of the Accuro 3S",
"has_exemption": false,
"start_date": "2026-07-15",
"completion_date": "2028-01-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03921008",
"publication_url": "https://clinicaltrials.gov/study/NCT03921008",
"title": "Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma",
"has_exemption": false,
"start_date": "2019-05-21",
"completion_date": "2028-01-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06570798",
"publication_url": "https://clinicaltrials.gov/study/NCT06570798",
"title": "A Phase 2, Open Label, Multicenter, Platform Trial to Assess the Safety, Tolerability, and Efficacy of Inebilizumab and Blinatumomab in Subjects With Autoimmune Diseases",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2028-01-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07079735",
"publication_url": "https://clinicaltrials.gov/study/NCT07079735",
"title": "VALganciclovir vs. LETermovir for Primary Prevention of CMV in Moderate to High-Risk Heart Transplant Recipients (The VALET-CMV Study)",
"has_exemption": false,
"start_date": "2025-09-12",
"completion_date": "2028-01-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06989437",
"publication_url": "https://clinicaltrials.gov/study/NCT06989437",
"title": "A Phase 2b/3, Randomized, Double-Blind Study to Investigate the Efficacy, Safety, and Tolerability of Ponsegromab (PF-06946860) Compared With Placebo Both With Background First-Line Chemotherapy in Adult Participants With Cachexia and Metastatic Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2028-01-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05038150",
"publication_url": "https://clinicaltrials.gov/study/NCT05038150",
"title": "Phase I/IIa, Open-label Study to Evaluate Safety, Tolerability and Preliminary Efficacy of Modified Salmonella Typhimurium SGN1 in Patients With Advanced Solid Tumor",
"has_exemption": false,
"start_date": "2023-01-16",
"completion_date": "2028-01-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Guangzhou Sinogen Pharmaceutical Co., Ltd",
"sponsor_slug": "guangzhou-sinogen-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940518",
"publication_url": "https://clinicaltrials.gov/study/NCT06940518",
"title": "Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2028-01-19",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07348692",
"publication_url": "https://clinicaltrials.gov/study/NCT07348692",
"title": "A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, Lot-to-lot Consistency, 4-arm Study to Investigate the Safety and Immunogenicity of a 4-dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers",
"has_exemption": false,
"start_date": "2026-01-20",
"completion_date": "2028-01-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05775718",
"publication_url": "https://clinicaltrials.gov/study/NCT05775718",
"title": "Safety and Immunogenicity of Shingrix Administered to Recipients of Allogeneic Peripheral and Cord Blood Stem Cell Transplants: Effect of Timing of Vaccination After Transplantation",
"has_exemption": false,
"start_date": "2023-10-24",
"completion_date": "2028-01-20",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06798324",
"publication_url": "https://clinicaltrials.gov/study/NCT06798324",
"title": "Using Non-Invasive Brain Stimulation (tDCS) as an Adjunct to Varenicline for the Treatment of Tobacco Dependence: a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-03-10",
"completion_date": "2028-01-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Centre for Addiction and Mental Health",
"sponsor_slug": "centre-for-addiction-and-mental-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06831136",
"publication_url": "https://clinicaltrials.gov/study/NCT06831136",
"title": "Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma; a Phase II Trial PANcreas CAncer RaDIofrequeNcy AbLation",
"has_exemption": false,
"start_date": "2025-03-26",
"completion_date": "2028-01-20",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07044336",
"publication_url": "https://clinicaltrials.gov/study/NCT07044336",
"title": "Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4 Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (Bluestar-Endometrial01)",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-01-20",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06421636",
"publication_url": "https://clinicaltrials.gov/study/NCT06421636",
"title": "A PHASE 2, TWO-PART, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF SUBCUTANEOUSLY ADMINISTERED REGN7999 (AN INHIBITOR OF TMPRSS6) IN PARTICIPANTS WITH IRON OVERLOAD DUE TO NON-TRANSFUSION DEPENDENT β-THALASSEMIA",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2028-01-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03793166",
"publication_url": "https://clinicaltrials.gov/study/NCT03793166",
"title": "PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]",
"has_exemption": false,
"start_date": "2019-06-07",
"completion_date": "2028-01-25",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06054555",
"publication_url": "https://clinicaltrials.gov/study/NCT06054555",
"title": "A Randomized, Double-Blind Study Evaluating the Efficacy, Safety, and Immunogenicity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Treatment-Naïve Unresectable or Metastatic Melanoma",
"has_exemption": false,
"start_date": "2023-11-02",
"completion_date": "2028-01-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06170788",
"publication_url": "https://clinicaltrials.gov/study/NCT06170788",
"title": "A Randomized, Open-label, Phase 3 Study of MK-2870 in Combination With Pembrolizumab Compared to Pembrolizumab Monotherapy in the First-line Treatment of Participants With Metastatic Non-small Cell Lung Cancer With PD-L1 TPS Greater Than or Equal to 50% (TroFuse-007)",
"has_exemption": false,
"start_date": "2023-12-15",
"completion_date": "2028-01-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07199361",
"publication_url": "https://clinicaltrials.gov/study/NCT07199361",
"title": "Uncovering the Mechanism of Pain Relief by Peripheral Transcutaneous Magnetic Stimulation",
"has_exemption": false,
"start_date": "2025-03-24",
"completion_date": "2028-01-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Florida International University",
"sponsor_slug": "florida-international-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05557591",
"publication_url": "https://clinicaltrials.gov/study/NCT05557591",
"title": "A Phase 2 Study of Cemiplimab (Anti-PD-1 Antibody) in Combination With BNT116 (FixVac Lung) Versus Cemiplimab Monotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With Tumors Expressing PD-L1 ≥50%",
"has_exemption": false,
"start_date": "2023-04-21",
"completion_date": "2028-01-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06906211",
"publication_url": "https://clinicaltrials.gov/study/NCT06906211",
"title": "Low Intensity Focused Ultrasound for Chronic Pain: High Resolution Targeting of The Human Insula",
"has_exemption": false,
"start_date": "2025-01-15",
"completion_date": "2028-01-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington D.C. Veterans Affairs Medical Center",
"sponsor_slug": "washington-dc-veterans-affairs-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04471727",
"publication_url": "https://clinicaltrials.gov/study/NCT04471727",
"title": "A Phase 1/2 Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and Pharmacokinetics of HPN328 Monotherapy and HPN328 With Atezolizumab or Ifinatamab Deruxtecan (I-DXd) in Patients With Advanced Cancers Associated With Expression of Delta-like Canonical Notch Ligand 3 (DLL3).",
"has_exemption": false,
"start_date": "2020-12-14",
"completion_date": "2028-01-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",
"sponsor_slug": "harpoon-therapeutics-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05734066",
"publication_url": "https://clinicaltrials.gov/study/NCT05734066",
"title": "A Phase 1/2, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Recommended Phase 2 Dose (RP2D), and Efficacy of Lurbinectedin Monotherapy in Pediatric Participants With Previously Treated Solid Tumors Followed by Expansion to Assess Efficacy and Safety in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma.",
"has_exemption": false,
"start_date": "2023-05-23",
"completion_date": "2028-01-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Jazz Pharmaceuticals",
"sponsor_slug": "jazz-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05902169",
"publication_url": "https://clinicaltrials.gov/study/NCT05902169",
"title": "A Randomized, Open-label, Multicentric, Two-arm Pivotal Trial of SonoCloud-9 Combined With Carboplatin (CBDCA) vs Standard of Care Lomustine (CCNU) or Temozolomide (TMZ) in Patients Undergoing Planned Resection for First Recurrence Glioblastoma.",
"has_exemption": false,
"start_date": "2024-01-29",
"completion_date": "2028-01-28",
"has_results": false,
"results_due": false,
"sponsor_name": "CarThera",
"sponsor_slug": "carthera",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06544291",
"publication_url": "https://clinicaltrials.gov/study/NCT06544291",
"title": "Combination of THC and CBD as Novel Treatment for Co-Occurring Opioid Use Disorder and Chronic Pain",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2028-01-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07438405",
"publication_url": "https://clinicaltrials.gov/study/NCT07438405",
"title": "An Open-label, Rollover Study for Participants With Thyroid Eye Disease Previously Enrolled in Amgen-sponsored AMG 732 Studies and Are Primary Proptosis Non-responders or Who Relapsed During the Safety Follow-up",
"has_exemption": false,
"start_date": "2026-02-25",
"completion_date": "2028-01-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04092192",
"publication_url": "https://clinicaltrials.gov/study/NCT04092192",
"title": "Prospective Comparison of Rigid Forceps Versus Endovascular Snare for Routine IVC Filter Retrieval",
"has_exemption": false,
"start_date": "2018-12-26",
"completion_date": "2028-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05010122",
"publication_url": "https://clinicaltrials.gov/study/NCT05010122",
"title": "A Phase I/II Study of ASTX727, Venetoclax, and Gilteritinib for Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome With an Activating FLT3 Mutation",
"has_exemption": false,
"start_date": "2021-07-08",
"completion_date": "2028-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06138977",
"publication_url": "https://clinicaltrials.gov/study/NCT06138977",
"title": "Controlling Locomotion Over Continuously Varying Activities for Agile Powered Prosthetic Legs",
"has_exemption": false,
"start_date": "2023-12-06",
"completion_date": "2028-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06564142",
"publication_url": "https://clinicaltrials.gov/study/NCT06564142",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy (RAINIER)",
"has_exemption": false,
"start_date": "2024-08-30",
"completion_date": "2028-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alpine Immune Sciences Inc, A Subsidiary of Vertex",
"sponsor_slug": "alpine-immune-sciences-inc-a-subsidiary-of-vertex",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05421858",
"publication_url": "https://clinicaltrials.gov/study/NCT05421858",
"title": "An Interventional Efficacy and Safety Phase 3 Double-blind 2-arm Study to Investigate IV Followed by Oral Fosmanogepix Compared With IV Caspofungin Followed by Oral Fluconazole in Adult Participants With Candidemia and/or Invasive Candidiasis",
"has_exemption": false,
"start_date": "2024-12-11",
"completion_date": "2028-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Basilea Pharmaceutica",
"sponsor_slug": "basilea-pharmaceutica",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06157151",
"publication_url": "https://clinicaltrials.gov/study/NCT06157151",
"title": "A Randomized, Open-label, Two-arm, Multicenter Phase 2 Study to Evaluate Efficacy and Safety of PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab Monotherapy in Patients With Recurrent or Metastatic Cervical Cancer.",
"has_exemption": false,
"start_date": "2025-03-21",
"completion_date": "2028-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Precigen, Inc",
"sponsor_slug": "precigen-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06852963",
"publication_url": "https://clinicaltrials.gov/study/NCT06852963",
"title": "A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 (30 μg and 75 μg) Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001 in the PLATYPUS Study (Protocol # VP001-101) or WALLABY Study (Protocol # VP001-102) for a Minimum of 8 Weeks",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2028-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "PYC Therapeutics",
"sponsor_slug": "pyc-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06294548",
"publication_url": "https://clinicaltrials.gov/study/NCT06294548",
"title": "A Phase Ib/II, Dose Escalation and Dose Expansion Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma (HCC)",
"has_exemption": false,
"start_date": "2025-07-29",
"completion_date": "2028-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06616155",
"publication_url": "https://clinicaltrials.gov/study/NCT06616155",
"title": "Study of JAK Inhibition in Stem-Like Prostate Cancer (JASPER): A Phase 1b/2a Multicenter Study of Ruxolitinib and Enzalutamide in Castration Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2028-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05393466",
"publication_url": "https://clinicaltrials.gov/study/NCT05393466",
"title": "A Phase I/II, Open-label Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2028-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Xcovery Holdings, Inc.",
"sponsor_slug": "xcovery-holdings-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00900575",
"publication_url": "https://clinicaltrials.gov/study/NCT00900575",
"title": "Cervical Cancer Detection Using Optical Spectroscopy",
"has_exemption": false,
"start_date": "2006-05-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01217931",
"publication_url": "https://clinicaltrials.gov/study/NCT01217931",
"title": "Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial",
"has_exemption": false,
"start_date": "2011-01-19",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01352520",
"publication_url": "https://clinicaltrials.gov/study/NCT01352520",
"title": "Phase II Trial of Brentuximab Vedotin (SGN-35) at Dose of 1.8 mg/kg IV Every 3 Weeks in Patients With CD30-positive Lymphoproliferative Disorders (Cutaneous Anaplastic Large T-cell Lymphoma (ALCL), Mycosis Fungoides, and Extensive Lymphomatoid Papulosis (LyP)",
"has_exemption": false,
"start_date": "2011-06-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02140255",
"publication_url": "https://clinicaltrials.gov/study/NCT02140255",
"title": "Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study",
"has_exemption": false,
"start_date": "2015-01-23",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02649959",
"publication_url": "https://clinicaltrials.gov/study/NCT02649959",
"title": "An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin",
"has_exemption": false,
"start_date": "2015-10-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Curemark",
"sponsor_slug": "curemark",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02525757",
"publication_url": "https://clinicaltrials.gov/study/NCT02525757",
"title": "DETERRED: PD-L1 blockadE To Evaluate the Safety of Lung CanceR Therapy Using Carboplatin, Paclitaxel, and Radiation CombinEd With MPDL3280A",
"has_exemption": false,
"start_date": "2016-01-26",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04242602",
"publication_url": "https://clinicaltrials.gov/study/NCT04242602",
"title": "Multimodal Monitoring of Cerebral Autoregulation After Pediatric Brain Injury",
"has_exemption": false,
"start_date": "2018-11-06",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02570984",
"publication_url": "https://clinicaltrials.gov/study/NCT02570984",
"title": "Controlling and Preventing Asthma Progression and Severity in Kids",
"has_exemption": false,
"start_date": "2018-11-27",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Children’s Hospital",
"sponsor_slug": "boston-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03900429",
"publication_url": "https://clinicaltrials.gov/study/NCT03900429",
"title": "A Phase 3, Multinational, Double-Blind, Randomized, Placebo-Controlled Study of MGL-3196 (Resmetirom) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Fibrosis to Resolve NASH and Reduce Progression to Cirrhosis and/or Hepatic Decompensation",
"has_exemption": true,
"start_date": "2019-03-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Madrigal Pharmaceuticals, Inc.",
"sponsor_slug": "madrigal-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03794076",
"publication_url": "https://clinicaltrials.gov/study/NCT03794076",
"title": "Cromoglicte Adjunctive Therapy for Outpatients With Schizophrenia",
"has_exemption": false,
"start_date": "2019-04-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vishwajit Nimgaonkar, MD PhD",
"sponsor_slug": "vishwajit-nimgaonkar-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04136353",
"publication_url": "https://clinicaltrials.gov/study/NCT04136353",
"title": "DASL-HiCaP: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801): A Randomised Phase 3 Double-blind, Placebo-controlled Trial of Adding Darolutamide to Androgen Deprivation Therapy and Definitive or Salvage Radiation in Very High Risk, Clinically Localised Prostate Cancer",
"has_exemption": false,
"start_date": "2020-03-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Sydney",
"sponsor_slug": "university-of-sydney",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04414475",
"publication_url": "https://clinicaltrials.gov/study/NCT04414475",
"title": "A Phase 2b, Open-label, Multi-arm Clinical Trial of Selinexor Plus Low-dose Dexamethasone (Sd) in Patients With Penta-refractory Multiple Myeloma or Selinexor and Bortezomib Plus Low-dose Dexamethasone (SVd) in Patients With Triple-class Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2020-07-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Karyopharm Therapeutics Inc",
"sponsor_slug": "karyopharm-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04643366",
"publication_url": "https://clinicaltrials.gov/study/NCT04643366",
"title": "Phase 2 Study of Total Neoadjuvant mFOLFOX and Short-Course Radiotherapy in Resectable Rectal Cancer",
"has_exemption": false,
"start_date": "2021-01-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04457596",
"publication_url": "https://clinicaltrials.gov/study/NCT04457596",
"title": "The CompassHER2 Trials (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer) CompassHER2 Residual Disease (RD), a Double-Blinded, Phase III Randomized Trial of T-DM1 Compared With T-DM1 and Tucatinib",
"has_exemption": false,
"start_date": "2021-03-02",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04667585",
"publication_url": "https://clinicaltrials.gov/study/NCT04667585",
"title": "Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx Using Metabolic Signature From Interim 18FDG-PET/CT",
"has_exemption": false,
"start_date": "2021-04-12",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04685590",
"publication_url": "https://clinicaltrials.gov/study/NCT04685590",
"title": "Phase II Clinical Trial to Evaluate the Safety and Feasibility of Senolytic Therapy in Alzheimer's Disease",
"has_exemption": false,
"start_date": "2021-12-22",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05127954",
"publication_url": "https://clinicaltrials.gov/study/NCT05127954",
"title": "A Multicenter, Open-label, Extension Study to Evaluate the Long-term Safety and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine With or Without Aura in Children and Adolescents (Ages 6-17)",
"has_exemption": false,
"start_date": "2022-01-14",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05130177",
"publication_url": "https://clinicaltrials.gov/study/NCT05130177",
"title": "Phase II Study of PD-1 Inhibitor Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma",
"has_exemption": false,
"start_date": "2022-03-16",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Diwakar Davar",
"sponsor_slug": "diwakar-davar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05504252",
"publication_url": "https://clinicaltrials.gov/study/NCT05504252",
"title": "METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin",
"has_exemption": false,
"start_date": "2022-10-05",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital, Akershus",
"sponsor_slug": "university-hospital-akershus",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04105270",
"publication_url": "https://clinicaltrials.gov/study/NCT04105270",
"title": "A Randomized Double Blind Phase II Trial of Restorative Microbiota Therapy (RMT) in Combination With Durvalumab (MEDI4736) and Chemotherapy in Untreated Patients With Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2022-11-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Masonic Cancer Center, University of Minnesota",
"sponsor_slug": "masonic-cancer-center-university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04936854",
"publication_url": "https://clinicaltrials.gov/study/NCT04936854",
"title": "Prospective Comparison of Sirolimus Against Corticosteroids in Treatment of Patients With Active Thyroid Eye Disease",
"has_exemption": false,
"start_date": "2023-01-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Haukeland University Hospital",
"sponsor_slug": "haukeland-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05470504",
"publication_url": "https://clinicaltrials.gov/study/NCT05470504",
"title": "Phase II Study of Growth Hormone Inhibition Using Pegvisomant In Severe Insulin Resistance",
"has_exemption": false,
"start_date": "2023-01-23",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05699343",
"publication_url": "https://clinicaltrials.gov/study/NCT05699343",
"title": "Surgical Treatment of Peri-implantitis Using a Bone Substitute With or Without a Resorbable Collagen Membrane. A Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2023-01-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Andrea Ravida",
"sponsor_slug": "andrea-ravida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05664789",
"publication_url": "https://clinicaltrials.gov/study/NCT05664789",
"title": "Targeting the Neurobiology of Restricted and Repetitive Behaviors in Children With Autism Using N-acetylcysteine: A Randomized, Controlled Trial",
"has_exemption": false,
"start_date": "2023-04-26",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05452564",
"publication_url": "https://clinicaltrials.gov/study/NCT05452564",
"title": "Phase II Study to Evaluate the Efficacy and Safety of Baricitinib for Reduction of HIV in the Central Nervous System",
"has_exemption": false,
"start_date": "2023-05-18",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "William Tyor",
"sponsor_slug": "william-tyor",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05985655",
"publication_url": "https://clinicaltrials.gov/study/NCT05985655",
"title": "A Phase 1/2 Open-label Multicenter Study to Assess the Safety, Pharmacokinetics, and Anti-tumor Activity of GTAEXS617 in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2023-07-06",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.",
"sponsor_slug": "exscientia-ai-ltd-a-wholly-owned-subsidiary-of-recursion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05746208",
"publication_url": "https://clinicaltrials.gov/study/NCT05746208",
"title": "A Phase II Study of Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors",
"has_exemption": false,
"start_date": "2023-07-17",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05867251",
"publication_url": "https://clinicaltrials.gov/study/NCT05867251",
"title": "A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-021 as a Single Agent and in Combination Therapy in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2023-08-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avenzo Therapeutics, Inc.",
"sponsor_slug": "avenzo-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05887609",
"publication_url": "https://clinicaltrials.gov/study/NCT05887609",
"title": "A Phase II Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine-gynx and Olaparib in Recurrent Platinum Sensitive Ovarian, Peritoneal, and Fallopian Tube Cancer",
"has_exemption": false,
"start_date": "2023-10-03",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06012240",
"publication_url": "https://clinicaltrials.gov/study/NCT06012240",
"title": "A Phase 3 Randomized, Placebo-controlled, Double-blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Severe Alopecia Areata",
"has_exemption": false,
"start_date": "2023-10-11",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05988710",
"publication_url": "https://clinicaltrials.gov/study/NCT05988710",
"title": "Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia",
"has_exemption": false,
"start_date": "2023-10-19",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06159673",
"publication_url": "https://clinicaltrials.gov/study/NCT06159673",
"title": "A Master Protocol for Three Independent, Seamlessly Enrolling, Double-blind, Placebo-controlled Efficacy and Safety Studies of ACP-204 in Adults With Alzheimer's Disease Psychosis",
"has_exemption": false,
"start_date": "2023-11-14",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ACADIA Pharmaceuticals Inc.",
"sponsor_slug": "acadia-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05872204",
"publication_url": "https://clinicaltrials.gov/study/NCT05872204",
"title": "A Phase II, Open-label, Multicenter Study of Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer",
"has_exemption": false,
"start_date": "2023-11-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Universitaire Ziekenhuizen KU Leuven",
"sponsor_slug": "universitaire-ziekenhuizen-ku-leuven",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06101342",
"publication_url": "https://clinicaltrials.gov/study/NCT06101342",
"title": "A Phase 2, Open-Label, Multicenter, Randomized Study to Evaluate the Pharmacokinetics and Safety of Twice Yearly Long-Acting Subcutaneous Lenacapavir for Pre-Exposure Prophylaxis in People Who Inject Drugs",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06106295",
"publication_url": "https://clinicaltrials.gov/study/NCT06106295",
"title": "Metyrapone Intervention in Patients With Mild Autonomous Cortisol Secretion (MACS)",
"has_exemption": false,
"start_date": "2023-12-19",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06199531",
"publication_url": "https://clinicaltrials.gov/study/NCT06199531",
"title": "A Phase 1/2/3 Open-label, Single Arm, Dose-finding Study to Investigate Long-term Safety, Tolerability and Efficacy of GS-100, an Adeno-associated Virus Serotype 9 (AAV9) Vector-mediated Gene Transfer of Human NGLY1, in Patients With NGLY1 Deficiency",
"has_exemption": false,
"start_date": "2024-02-13",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Grace Science, LLC",
"sponsor_slug": "grace-science-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05512143",
"publication_url": "https://clinicaltrials.gov/study/NCT05512143",
"title": "Targeting the Brain-heart Axis With TMS Among Reproductive Aged Women With PTSD",
"has_exemption": false,
"start_date": "2024-02-15",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Lifespan",
"sponsor_slug": "lifespan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06094816",
"publication_url": "https://clinicaltrials.gov/study/NCT06094816",
"title": "Forebrain Electroneutral Transporters in Salt-sensitive Hypertension: an MRI Study",
"has_exemption": false,
"start_date": "2024-03-05",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Delaware",
"sponsor_slug": "university-of-delaware",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06192758",
"publication_url": "https://clinicaltrials.gov/study/NCT06192758",
"title": "An Early Feasibility Study to Evaluate the Safety of the TheraSphere Prostate Cancer (PCa) Device in Patients With Clinically Localized Prostate Cancer",
"has_exemption": false,
"start_date": "2024-04-15",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05419492",
"publication_url": "https://clinicaltrials.gov/study/NCT05419492",
"title": "ENDEAVOR: A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Infants and Children With SCN1A-Positive Dravet Syndrome",
"has_exemption": false,
"start_date": "2024-05-14",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Encoded Therapeutics",
"sponsor_slug": "encoded-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06240312",
"publication_url": "https://clinicaltrials.gov/study/NCT06240312",
"title": "Optic Nerve Head Strain as Biomarker for Glaucoma",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06252649",
"publication_url": "https://clinicaltrials.gov/study/NCT06252649",
"title": "Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb for Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)",
"has_exemption": false,
"start_date": "2024-07-17",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05968664",
"publication_url": "https://clinicaltrials.gov/study/NCT05968664",
"title": "Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ashwin Viswanathan",
"sponsor_slug": "ashwin-viswanathan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06508658",
"publication_url": "https://clinicaltrials.gov/study/NCT06508658",
"title": "A Phase 3, Multicenter, Randomized, Open-Label Study of Epcoritamab Plus Lenalidomide Compared to Rituximab Plus Gemcitabine and Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-08-13",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06544733",
"publication_url": "https://clinicaltrials.gov/study/NCT06544733",
"title": "An Operationally Seamless Phase 2/3, Randomized, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of GS-1720 in Combination With GS-4182 Versus Biktarvy in Virologically Suppressed People With HIV-1",
"has_exemption": false,
"start_date": "2024-08-20",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05696366",
"publication_url": "https://clinicaltrials.gov/study/NCT05696366",
"title": "Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes",
"has_exemption": false,
"start_date": "2024-09-09",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525220",
"publication_url": "https://clinicaltrials.gov/study/NCT06525220",
"title": "A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Recurrent or Metastatic PD-L1+ Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-09-25",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merus B.V.",
"sponsor_slug": "merus-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06240754",
"publication_url": "https://clinicaltrials.gov/study/NCT06240754",
"title": "A Pilot Study of Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2: A Decentralized Trial",
"has_exemption": false,
"start_date": "2024-10-10",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06494631",
"publication_url": "https://clinicaltrials.gov/study/NCT06494631",
"title": "Clinical Study to Assess the Safety and Performance of the Xeltis Hemodialysis Access Graft",
"has_exemption": false,
"start_date": "2024-11-11",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Xeltis",
"sponsor_slug": "xeltis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06027099",
"publication_url": "https://clinicaltrials.gov/study/NCT06027099",
"title": "Integrating Tailored Postoperative Opioid Tapering and Pain Management Support for Patients on Long-Term Opioid Use Presenting for Spine Surgery",
"has_exemption": false,
"start_date": "2024-12-05",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06763315",
"publication_url": "https://clinicaltrials.gov/study/NCT06763315",
"title": "The Efficacy, Safety, and Long-Term Prognosis of Low-Dose Selumetinib in the Treatment of Neurofibromatosis Type 1 Associated Plexiform Neurofibromas in Chinese Children: a Multicenter Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "West China Hospital",
"sponsor_slug": "west-china-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06807359",
"publication_url": "https://clinicaltrials.gov/study/NCT06807359",
"title": "Open-label Clinical Phase 1/2 Study to Assess the Safety and Efficacy of the SpectraCure P18 System and Verteporfin for Injection for the Treatment of Primary Localized Prostate Cancer",
"has_exemption": false,
"start_date": "2025-01-06",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SpectraCure AB",
"sponsor_slug": "spectracure-ab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06773195",
"publication_url": "https://clinicaltrials.gov/study/NCT06773195",
"title": "A Phase 1/2 Study of Combined JAK/ERK Inhibition in Patients With Myelofibrosis",
"has_exemption": false,
"start_date": "2025-01-07",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06504381",
"publication_url": "https://clinicaltrials.gov/study/NCT06504381",
"title": "A Phase I/IIa Study to Evaluate the Efficacy of DB107-RRV (Formerly Toca511), Administered to Subjects at Time of Resection and Intravenously Thereafter, in Combination With DB107-FC (Formerly Toca FC) and Radiation Therapy or DB107-FC, Temozolomide (TMZ) and Radiation Therapy in Patients With Newly Diagnosed High Grade Glioma",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06743126",
"publication_url": "https://clinicaltrials.gov/study/NCT06743126",
"title": "A Prospective, Multicenter, Open-label, Randomized, Actively Controlled, Parallel-group Phase 3 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of IMA203 Versus Investigator's Choice of Treatment in Patients With Previously Treated, Unresectable or Metastatic Cutaneous Melanoma (ACTengine® IMA203-301)",
"has_exemption": false,
"start_date": "2025-01-14",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Immatics US, Inc.",
"sponsor_slug": "immatics-us-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06765317",
"publication_url": "https://clinicaltrials.gov/study/NCT06765317",
"title": "Optimizing Frontline Therapy for DLBCL in Older Adults: A GLOfitamab-based, Response-adapted, Window-stYle Study (GLORY)",
"has_exemption": false,
"start_date": "2025-01-16",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06726122",
"publication_url": "https://clinicaltrials.gov/study/NCT06726122",
"title": "Clinical Study to Evaluate the Efficacy and Safety of Matrix Pro Treatment for Facial, Submental and Neck Laxity",
"has_exemption": false,
"start_date": "2025-01-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Candela Corporation",
"sponsor_slug": "candela-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06478017",
"publication_url": "https://clinicaltrials.gov/study/NCT06478017",
"title": "Belatacept With Delayed Tacrolimus Withdrawal Versus Standard-of-Care Tacrolimus in Heart Transplant Recipients (RTB-013)",
"has_exemption": false,
"start_date": "2025-01-29",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06672575",
"publication_url": "https://clinicaltrials.gov/study/NCT06672575",
"title": "A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma",
"has_exemption": false,
"start_date": "2025-01-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06854653",
"publication_url": "https://clinicaltrials.gov/study/NCT06854653",
"title": "An Open-Label, Phase 2 Study of PTX-100 Monotherapy in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.",
"has_exemption": false,
"start_date": "2025-03-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prescient Therapeutics, Ltd.",
"sponsor_slug": "prescient-therapeutics-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06470282",
"publication_url": "https://clinicaltrials.gov/study/NCT06470282",
"title": "EV-PRIME: Phase Ib/II Study of Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy as a Bladder-Sparing Trimodality Therapy in Muscle Invasive Bladder Cancer",
"has_exemption": false,
"start_date": "2025-03-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06710756",
"publication_url": "https://clinicaltrials.gov/study/NCT06710756",
"title": "A Phase I/IIa Image-Guided, Alpha-Particle Therapy Study of [203Pb]Pb-PSV359 and [212Pb]Pb-PSV359 in Patients With Solid Tumors That Are Known to be Fibroblast Activation Protein (FAP)-Positive",
"has_exemption": false,
"start_date": "2025-04-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Perspective Therapeutics",
"sponsor_slug": "perspective-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06382272",
"publication_url": "https://clinicaltrials.gov/study/NCT06382272",
"title": "Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy",
"has_exemption": false,
"start_date": "2025-05-14",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07128602",
"publication_url": "https://clinicaltrials.gov/study/NCT07128602",
"title": "Determining the Effects of Non-invasive Brain Stimulation to Improve Quadriceps Muscle Function After ACL Reconstruction.",
"has_exemption": false,
"start_date": "2025-06-05",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Arcadia University",
"sponsor_slug": "arcadia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699836",
"publication_url": "https://clinicaltrials.gov/study/NCT06699836",
"title": "A Phase Two Study Evaluating Two Doses of Leronlimab (Pro 140) In Combination With Trifluridine + Tipiracil (TAS-102) + Bevacizumab in Participants With CCR5+, Microsatellite Stable (MSS), Relapsed Refractory Metastatic Colorectal Cancer (mCRC)",
"has_exemption": false,
"start_date": "2025-06-16",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CytoDyn, Inc.",
"sponsor_slug": "cytodyn-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06991114",
"publication_url": "https://clinicaltrials.gov/study/NCT06991114",
"title": "An Open-label Phase 2a Study to Evaluate the Safety and Efficacy of AlloNK®, an Allogeneic Cord Blood-derived NK Cell Therapy, in Combination With Rituximab in Relapsing Forms of B-cell Dependent Rheumatologic Diseases",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Artiva Biotherapeutics, Inc.",
"sponsor_slug": "artiva-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06973668",
"publication_url": "https://clinicaltrials.gov/study/NCT06973668",
"title": "A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07148128",
"publication_url": "https://clinicaltrials.gov/study/NCT07148128",
"title": "An Open-label, Multicenter, Phase 1/2a Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antitumour Activity of WEF-001 in Participants With Advanced KRAS- Mutant Solid Tumours.",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Auricula Biosciences Inc.",
"sponsor_slug": "auricula-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07384689",
"publication_url": "https://clinicaltrials.gov/study/NCT07384689",
"title": "MiAMII Study - Microdialysis Acquired SaMpling of Ischemia, Inflammation and Antibiotics Locally in Amputation Stump: A Comparative Study in Diabetic and Non-Diabetic Patients Undergoing Non-Traumatic Transfemoral Amputation",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Aarhus",
"sponsor_slug": "university-of-aarhus",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06954831",
"publication_url": "https://clinicaltrials.gov/study/NCT06954831",
"title": "Phase 2 Trial of Ultra-Hypofractionated Whole Breast Irradiation With Concomitant Lumpectomy Cavity Boost",
"has_exemption": false,
"start_date": "2025-08-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05361915",
"publication_url": "https://clinicaltrials.gov/study/NCT05361915",
"title": "A Phase 2 Study of AbiVERtinib in Combination With Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (Maverick Trial)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sorrento Therapeutics, Inc.",
"sponsor_slug": "sorrento-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06801015",
"publication_url": "https://clinicaltrials.gov/study/NCT06801015",
"title": "A Randomized, Placebo-Controlled Trial of the Effects of Long-Acting GLP-1 or Dual Incretin (GLP-1 and GIP) Modulation on Gastric Motor Functions",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221500",
"publication_url": "https://clinicaltrials.gov/study/NCT07221500",
"title": "A Single-arm, Phase 2, Open-label, Multicenter Study to Evaluate NX-5948 in Adults With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Previously Exposed to a Bruton's Tyrosine Kinase Inhibitor (BTKi) and a B-cell Lymphoma-2 Inhibitor (BCL-2i)",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nurix Therapeutics, Inc.",
"sponsor_slug": "nurix-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07107204",
"publication_url": "https://clinicaltrials.gov/study/NCT07107204",
"title": "A Multicenter, Open-label, Single-arm Phase Ib/IIa Clinical Study to Evaluate the Safety and Efficacy of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biotroy Therapeutics",
"sponsor_slug": "biotroy-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07107971",
"publication_url": "https://clinicaltrials.gov/study/NCT07107971",
"title": "Drug-Eluting Balloon Treatment Versus Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-11-04",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)",
"sponsor_slug": "academisch-medisch-centrum-universiteit-van-amsterdam-amc-uva",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06914765",
"publication_url": "https://clinicaltrials.gov/study/NCT06914765",
"title": "A Pilot Study Evaluating the Safety and Efficacy of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adolescents",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07283822",
"publication_url": "https://clinicaltrials.gov/study/NCT07283822",
"title": "A Phase II Trial of JAK Inhibitor Added to Immunotherapy for Treatment of Relapsed/Refractory T-cell Lymphoma and 9p Amplified Lymphomas",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Seda S. Tolu",
"sponsor_slug": "seda-s-tolu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07353905",
"publication_url": "https://clinicaltrials.gov/study/NCT07353905",
"title": "Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor Research Institute",
"sponsor_slug": "baylor-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282600",
"publication_url": "https://clinicaltrials.gov/study/NCT07282600",
"title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Obesity or Overweight, and Type 2 Diabetes",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07265479",
"publication_url": "https://clinicaltrials.gov/study/NCT07265479",
"title": "A Randomized, Double-Blind, Vehicle-Controlled (Period 1) and Open-Label (Period 2) Phase 3 Study to Investigate the Safety and Efficacy of Tapinarof Cream, 1% in Pediatric Participants Ages 3 Months to < 24 Months With Atopic Dermatitis",
"has_exemption": false,
"start_date": "2025-12-29",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Organon and Co",
"sponsor_slug": "organon-and-co",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847360",
"publication_url": "https://clinicaltrials.gov/study/NCT06847360",
"title": "Home-Based Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Pain and Symptom Management Among Young Adults With Irritable Bowel Syndrome (IBS)",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220304",
"publication_url": "https://clinicaltrials.gov/study/NCT07220304",
"title": "CaRi-Heart® Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA): A Prospective U.S. Community-Based Study on the Impact of CaRi-Heart® Analysis in Patients Undergoing CCTA for Coronary Artery Disease",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Corazon Medical PC",
"sponsor_slug": "corazon-medical-pc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282340",
"publication_url": "https://clinicaltrials.gov/study/NCT07282340",
"title": "Phentermine's Impact on Treatment in Teens (PhITT): A Randomized Placebo-Controlled Trial of Phentermine for Adolescents With Obesity",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Russell McCulloh, MD",
"sponsor_slug": "russell-mcculloh-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223892",
"publication_url": "https://clinicaltrials.gov/study/NCT07223892",
"title": "A Prospective Controlled Trial Evaluating the Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds: A Stratified Analysis by Wound Etiology and Care Setting",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bardia Anvar",
"sponsor_slug": "bardia-anvar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07300852",
"publication_url": "https://clinicaltrials.gov/study/NCT07300852",
"title": "The Effectiveness of DSLT in Asian Normal Tension Glaucoma Patients",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ngoc Nguyen Inc.",
"sponsor_slug": "ngoc-nguyen-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07354711",
"publication_url": "https://clinicaltrials.gov/study/NCT07354711",
"title": "A Phase I/II Study of 3H-10000 (an Anti-FGFR2b Antibody-Drug Conjugate) in Subjects With Unresectable or Metastatic Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2026-01-04",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "3H Pharmaceuticals Co., Ltd.",
"sponsor_slug": "3h-pharmaceuticals-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284511",
"publication_url": "https://clinicaltrials.gov/study/NCT07284511",
"title": "Fully Closed-Loop Glucose Control in Adults With Type 1 Diabetes Using Tirzepatide: a Randomized, Multi-center, Open-label, Non-inferiority, Parallel Trial",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Melissa-Rosina Pasqua",
"sponsor_slug": "melissa-rosina-pasqua",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07392242",
"publication_url": "https://clinicaltrials.gov/study/NCT07392242",
"title": "A Phase II Study of IDH1 Inhibition With Ivosidenib as Maintenance Therapy After Ivosidenib, Azacitidine, and Venetoclax for Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2026-01-27",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228039",
"publication_url": "https://clinicaltrials.gov/study/NCT07228039",
"title": "A Double-Blind Prospective RCT Assessment of ESP Blocks for Analgesia Following Posterior Spinal Fusion",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07247006",
"publication_url": "https://clinicaltrials.gov/study/NCT07247006",
"title": "Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07308964",
"publication_url": "https://clinicaltrials.gov/study/NCT07308964",
"title": "A Comparative Study of Shortened (4-Infusion) Versus Standard (8-Infusion) Teprotumumab Regimens in Patients With Thyroid Eye Disease (TED) Exhibiting an Early Optimal Clinical Response",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sheba Medical Center",
"sponsor_slug": "sheba-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07349771",
"publication_url": "https://clinicaltrials.gov/study/NCT07349771",
"title": "Phase II Double-Blinded Placebo-Controlled Randomized Trial of CSF-1R Inhibitor, Axatilimab for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell Transplantation (ABRAXAS)",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07430085",
"publication_url": "https://clinicaltrials.gov/study/NCT07430085",
"title": "Postoperative Pain Outcomes After Use of Bupivacaine-Meloxicam Extended-Release Solution in Robot Assisted Total Knee Arthroplasty: A Prospective Study",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)",
"sponsor_slug": "allegheny-singer-research-institute-also-known-as-allegheny-health-network-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07432633",
"publication_url": "https://clinicaltrials.gov/study/NCT07432633",
"title": "A Phase 1/2 Study of [18F]FPyQCP for PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Blue Earth Diagnostics",
"sponsor_slug": "blue-earth-diagnostics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214597",
"publication_url": "https://clinicaltrials.gov/study/NCT07214597",
"title": "NICU Utilization of Remote Voice Technology to Improve mateRnal Experience (NURTURE): A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-02-04",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07217678",
"publication_url": "https://clinicaltrials.gov/study/NCT07217678",
"title": "Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use",
"has_exemption": false,
"start_date": "2026-02-09",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07387367",
"publication_url": "https://clinicaltrials.gov/study/NCT07387367",
"title": "A Phase 3, Multicenter, Prospective, Randomized, Open-label Efficacy and Safety Study of Intravenous Brincidofovir Versus Intravenous Cidofovir for Treatment of Adenovirus Infection in Pediatric and Adult Subjects After Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)",
"has_exemption": false,
"start_date": "2026-02-15",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SymBio Pharmaceuticals",
"sponsor_slug": "symbio-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07362082",
"publication_url": "https://clinicaltrials.gov/study/NCT07362082",
"title": "A Randomized Clinical Trial of Telehealth Treatment for Opioid Use Disorders",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07369089",
"publication_url": "https://clinicaltrials.gov/study/NCT07369089",
"title": "KETAMORE: TARGETING TREATMENT-RESISTANT OUD WITH KETAMINE-ASSISTED MINDFULNESS-ORIENTED RECOVERY ENHANCEMENT",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07448038",
"publication_url": "https://clinicaltrials.gov/study/NCT07448038",
"title": "A Phase IIa, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Selnoflast in Reducing Vascular Inflammation in Patients With Atherosclerosis at Risk for Major Adverse Cardiac Events",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07209267",
"publication_url": "https://clinicaltrials.gov/study/NCT07209267",
"title": "Baricitinib Curative Repression of HIV-1",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224009",
"publication_url": "https://clinicaltrials.gov/study/NCT07224009",
"title": "Phase II Clinical Trial Evaluating the Safety and Efficacy of Low Dose Naltrexone (LDN) for the Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arkansas",
"sponsor_slug": "university-of-arkansas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06738368",
"publication_url": "https://clinicaltrials.gov/study/NCT06738368",
"title": "Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) ± Rituximab + Recombinant Erwinia Asparaginase (JZP458; Rylaze®) for the Treatment of Newly-Diagnosed Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Lymphoma/Leukemia",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07406360",
"publication_url": "https://clinicaltrials.gov/study/NCT07406360",
"title": "A Phase 3a, Observer Blind, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of Intramuscular Administration of an Investigational Combined Measles, Mumps, Rubella, and Varicella Vaccine Compared With Intramuscular Administration of ProQuad When Administered as a Second Dose to Healthy Children Aged 15 Months to 6 Years of Age",
"has_exemption": false,
"start_date": "2026-04-13",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07459634",
"publication_url": "https://clinicaltrials.gov/study/NCT07459634",
"title": "A Phase 2, Multicenter, Open-Label, Single-Arm Study of Lurbinectedin in Combination With Durvalumab as First-line Maintenance Therapy in Participants With Extensive-Stage Small-Cell Lung Cancer Following Induction Treatment With Platinum Based Chemotherapy and Durvalumab",
"has_exemption": false,
"start_date": "2026-04-25",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jazz Pharmaceuticals",
"sponsor_slug": "jazz-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07303777",
"publication_url": "https://clinicaltrials.gov/study/NCT07303777",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Efficacy, Safety, and Population Pharmacokinetics (PopPK) Profile of ABP-745 in Patients With Atherosclerosis",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Atom Therapeutics Co., Ltd",
"sponsor_slug": "atom-therapeutics-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07124559",
"publication_url": "https://clinicaltrials.gov/study/NCT07124559",
"title": "Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV",
"has_exemption": false,
"start_date": "2026-05-15",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07465718",
"publication_url": "https://clinicaltrials.gov/study/NCT07465718",
"title": "Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Orphalan",
"sponsor_slug": "orphalan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07322133",
"publication_url": "https://clinicaltrials.gov/study/NCT07322133",
"title": "Dopamine vs. Norepinephrine in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure and Systemic Hypotension Due to Pulmonary Hypertension: A Pilot Trial",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216586",
"publication_url": "https://clinicaltrials.gov/study/NCT07216586",
"title": "Comparing Opioid Consumption Following Total Knee Arthroplasty With The Perioperative Administration of Zynrelef Versus Adductor Canal Block",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06419985",
"publication_url": "https://clinicaltrials.gov/study/NCT06419985",
"title": "A Phase 2 Single-arm, Open Label Clinical Trial to Evaluate the Efficacy of Ketamine HCl Prolonged Release Tablets in Participants With Complex Regional Pain Syndrome",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Southern California",
"sponsor_slug": "university-of-southern-california",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07397611",
"publication_url": "https://clinicaltrials.gov/study/NCT07397611",
"title": "PRE-surgical NEOadjuvant Sandwich Immunotherapy With HIF inhibiTion in Renal Cell Carcinoma (PRENEOSHIFT-RCC)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07433673",
"publication_url": "https://clinicaltrials.gov/study/NCT07433673",
"title": "A Phase 2 Single-arm Study of Cemiplimab, Added to Typical Chemotherapy (Gemcitabine, Cisplatin, Nab-paclitaxel) for Down-staging of Locally Advanced, Unresectable Biliary Tract Cancer",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07237737",
"publication_url": "https://clinicaltrials.gov/study/NCT07237737",
"title": "Wound Healing Outcomes With and Without the Alexis Wound Retractor in Direct Anterior Approach Total Hip Arthroplasty",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05179577",
"publication_url": "https://clinicaltrials.gov/study/NCT05179577",
"title": "A Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Investigate the Safety and Efficacy of Arbaclofen Extended-Release Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis (Study OS440-3006)",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2028-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "RVL Pharmaceuticals, Inc.",
"sponsor_slug": "rvl-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01515527",
"publication_url": "https://clinicaltrials.gov/study/NCT01515527",
"title": "Phase II Study of Cladribine Plus Low Dose Cytarabine (LDAC) Induction Followed By Consolidation With Cladribine Plus LDAC Alternating With Decitabine in Patients With Untreated Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)",
"has_exemption": false,
"start_date": "2012-02-07",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04107181",
"publication_url": "https://clinicaltrials.gov/study/NCT04107181",
"title": "A Pilot Study Continuation to Assess the Use of an Introducer \"Calla\" During Cervical Cancer Screening",
"has_exemption": false,
"start_date": "2016-04-14",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02977780",
"publication_url": "https://clinicaltrials.gov/study/NCT02977780",
"title": "INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)",
"has_exemption": false,
"start_date": "2017-02-09",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Patrick Wen, MD",
"sponsor_slug": "patrick-wen-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03934372",
"publication_url": "https://clinicaltrials.gov/study/NCT03934372",
"title": "An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Ponatinib for the Treatment of Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors in Pediatric Participants",
"has_exemption": false,
"start_date": "2020-01-29",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Biosciences International Sàrl",
"sponsor_slug": "incyte-biosciences-international-sarl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04620187",
"publication_url": "https://clinicaltrials.gov/study/NCT04620187",
"title": "A Phase II Study of Adjuvant Ado-trastuzumab Emtansine (T-DM1) in HER2-positive Salivary Gland Carcinomas",
"has_exemption": false,
"start_date": "2020-12-24",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05039632",
"publication_url": "https://clinicaltrials.gov/study/NCT05039632",
"title": "Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies",
"has_exemption": false,
"start_date": "2023-05-08",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05949099",
"publication_url": "https://clinicaltrials.gov/study/NCT05949099",
"title": "Phase II Study of Cryoablation and Nirogacestat for Desmoid Tumor",
"has_exemption": false,
"start_date": "2023-08-15",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nam Bui",
"sponsor_slug": "nam-bui",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05819853",
"publication_url": "https://clinicaltrials.gov/study/NCT05819853",
"title": "Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome",
"has_exemption": false,
"start_date": "2023-11-03",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05386394",
"publication_url": "https://clinicaltrials.gov/study/NCT05386394",
"title": "Phase II Clinical Trial of Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia",
"has_exemption": false,
"start_date": "2024-02-13",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06127407",
"publication_url": "https://clinicaltrials.gov/study/NCT06127407",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Study of Ivosidenib in Participants ≥18 Years of Age With Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen",
"has_exemption": false,
"start_date": "2024-07-09",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Servier Bio-Innovation LLC",
"sponsor_slug": "servier-bio-innovation-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06336655",
"publication_url": "https://clinicaltrials.gov/study/NCT06336655",
"title": "Physiology of Unloading VA ECMO Trial",
"has_exemption": false,
"start_date": "2024-10-02",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06617858",
"publication_url": "https://clinicaltrials.gov/study/NCT06617858",
"title": "Open-label Phase 2 Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment",
"has_exemption": false,
"start_date": "2024-12-04",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06867549",
"publication_url": "https://clinicaltrials.gov/study/NCT06867549",
"title": "Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Stage II",
"has_exemption": false,
"start_date": "2025-03-04",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940180",
"publication_url": "https://clinicaltrials.gov/study/NCT06940180",
"title": "Perioperative Chemoimmunotherapy With Toripalimab for Sinonasal Cancer",
"has_exemption": false,
"start_date": "2025-06-17",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Glenn J. Hanna",
"sponsor_slug": "glenn-j-hanna",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05999383",
"publication_url": "https://clinicaltrials.gov/study/NCT05999383",
"title": "Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04433572",
"publication_url": "https://clinicaltrials.gov/study/NCT04433572",
"title": "Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Temsirolimus Perivascular Injection 0.1 mg/mL on the Incidence of Ischemia-Driven Major Amputation, Clinically Driven Target Lesion Revascularization, and Clinically Relevant Target Lesion Occlusion After Revascularization of Lesions Below the Knee in Patients With Symptomatic Rutherford 3-5 Peripheral Artery Disease",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mercator MedSystems, Inc.",
"sponsor_slug": "mercator-medsystems-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06445166",
"publication_url": "https://clinicaltrials.gov/study/NCT06445166",
"title": "A Multicenter Phase II Study of Propranolol for the Treatment of Kaposi Sarcoma in Adults",
"has_exemption": false,
"start_date": "2025-08-20",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07085338",
"publication_url": "https://clinicaltrials.gov/study/NCT07085338",
"title": "A Phase II Study With a Safety Run-In of the Addition of N-803, a Novel IL-15 Super-Agonist, to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2025-11-10",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213466",
"publication_url": "https://clinicaltrials.gov/study/NCT07213466",
"title": "Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder - OBOE-Mayo",
"has_exemption": false,
"start_date": "2026-01-19",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07133425",
"publication_url": "https://clinicaltrials.gov/study/NCT07133425",
"title": "A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-02-05",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07009899",
"publication_url": "https://clinicaltrials.gov/study/NCT07009899",
"title": "BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07441122",
"publication_url": "https://clinicaltrials.gov/study/NCT07441122",
"title": "Building Cognitive Reserve Through Brain-Computer-Interfaces",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07461961",
"publication_url": "https://clinicaltrials.gov/study/NCT07461961",
"title": "CORTISHOCK-P: A Randomized Pilot Trial of Corticosteroids as a Pharmacologic Adjunct to Temporary Mechanical Circulatory Support in Inflammation-Enriched Heart Failure Cardiogenic Shock",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07477054",
"publication_url": "https://clinicaltrials.gov/study/NCT07477054",
"title": "A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System - The AERO-PAS Study",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2028-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Lungpacer Medical Inc.",
"sponsor_slug": "lungpacer-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07205822",
"publication_url": "https://clinicaltrials.gov/study/NCT07205822",
"title": "A Phase IIIb, Open-label, Multinational Study Assessing the Efficacy and Safety of Dato-DXd Treatment in Patients With HRpositive, HER2 IHC 0, Locally Advanced Inoperable or Metastatic Breast Cancer Refractory to Endocrine Therapy (TROPION-Breast06)",
"has_exemption": false,
"start_date": "2025-10-30",
"completion_date": "2028-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06813911",
"publication_url": "https://clinicaltrials.gov/study/NCT06813911",
"title": "A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Atherosclerotic Cardiovascular Disease (ASCVD), and Elevated LDL-C and Lp(a)",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2028-02-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219407",
"publication_url": "https://clinicaltrials.gov/study/NCT07219407",
"title": "An Open-label, Long-term Study Evaluating RAP-219 in Adult Participants With Refractory Onset Seizures",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2028-02-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Rapport Therapeutics Inc.",
"sponsor_slug": "rapport-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06830798",
"publication_url": "https://clinicaltrials.gov/study/NCT06830798",
"title": "A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2028-02-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexion Pharmaceuticals, Inc.",
"sponsor_slug": "alexion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223138",
"publication_url": "https://clinicaltrials.gov/study/NCT07223138",
"title": "A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2025-11-13",
"completion_date": "2028-02-04",
"has_results": false,
"results_due": false,
"sponsor_name": "MoonLake Immunotherapeutics AG",
"sponsor_slug": "moonlake-immunotherapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03173924",
"publication_url": "https://clinicaltrials.gov/study/NCT03173924",
"title": "Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer",
"has_exemption": false,
"start_date": "2017-06-06",
"completion_date": "2028-02-06",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06091254",
"publication_url": "https://clinicaltrials.gov/study/NCT06091254",
"title": "A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 X Anti-CD3 Bispecific Antibody Versus Investigator's Choice in Previously Untreated Participants With Follicular Lymphoma (OLYMPIA-1)",
"has_exemption": false,
"start_date": "2023-12-12",
"completion_date": "2028-02-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03946878",
"publication_url": "https://clinicaltrials.gov/study/NCT03946878",
"title": "An Open Label, Phase II Investigator Initiated Study of Venetoclax and Acalabrutinib in Previously Treated Relapsed/Refractory Patients With Mantle Cell Lymphoma (MCL)",
"has_exemption": false,
"start_date": "2019-08-13",
"completion_date": "2028-02-08",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04771130",
"publication_url": "https://clinicaltrials.gov/study/NCT04771130",
"title": "A Phase 1b/2, Open-Label, Dose Finding, and Expansion Study of the Bcl-2 Inhibitor BGB-11417 in Patients With Myeloid Malignancies",
"has_exemption": false,
"start_date": "2021-05-24",
"completion_date": "2028-02-08",
"has_results": false,
"results_due": false,
"sponsor_name": "BeiGene",
"sponsor_slug": "beigene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06456463",
"publication_url": "https://clinicaltrials.gov/study/NCT06456463",
"title": "A Phase II Multicenter Open-label Trial of Tagraxofusp (Tag) in Combination With Venetoclax and Azacitidine (Ven/Aza) in Adults With Previously Untreated CD123+ Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy",
"has_exemption": false,
"start_date": "2025-01-14",
"completion_date": "2028-02-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Stemline Therapeutics, Inc.",
"sponsor_slug": "stemline-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219043",
"publication_url": "https://clinicaltrials.gov/study/NCT07219043",
"title": "A Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase 2 Trial Evaluating the Efficacy and Safety of Felzartamab in Recipients of Kidney Transplants With Late Isolated Microvascular Inflammation (MVI)",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2028-02-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525636",
"publication_url": "https://clinicaltrials.gov/study/NCT06525636",
"title": "A Multicenter, Open-label, Phase 1/2, Dose-escalation and Subsequent Safety Extension Study of Subcutaneous KK8123 in Adult Patients With X-linked Hypophosphatemia",
"has_exemption": false,
"start_date": "2024-10-09",
"completion_date": "2028-02-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Kyowa Kirin Co., Ltd.",
"sponsor_slug": "kyowa-kirin-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05201066",
"publication_url": "https://clinicaltrials.gov/study/NCT05201066",
"title": "An Open-label, Multicenter, Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.",
"has_exemption": false,
"start_date": "2023-02-13",
"completion_date": "2028-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06581198",
"publication_url": "https://clinicaltrials.gov/study/NCT06581198",
"title": "A Phase 2, Open-label, Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel in Patients With Active, Refractory Systemic Lupus Erythematosus (SLE) or Active, Refractory Lupus Nephritis (LN).",
"has_exemption": false,
"start_date": "2024-09-04",
"completion_date": "2028-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06311721",
"publication_url": "https://clinicaltrials.gov/study/NCT06311721",
"title": "A Randomized, Double-Blind Study to Compare Efficacy, Pharmacokinetics, Safety, and Immunogenicity Between ABP 234 and Keytruda® (Pembrolizumab) in Subjects With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-09-09",
"completion_date": "2028-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06542250",
"publication_url": "https://clinicaltrials.gov/study/NCT06542250",
"title": "A Modular Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With Relapsed or Refractory B-Cell Malignancies (TITANium)",
"has_exemption": false,
"start_date": "2024-09-18",
"completion_date": "2028-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226882",
"publication_url": "https://clinicaltrials.gov/study/NCT07226882",
"title": "A PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF DIFFERENT VACCINATION SCHEDULES OF 6-VALENT OSPA-BASED LYME DISEASE VACCINE, VLA15, IN HEALTHY ADULT PARTICIPANTS",
"has_exemption": false,
"start_date": "2025-11-19",
"completion_date": "2028-02-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05363709",
"publication_url": "https://clinicaltrials.gov/study/NCT05363709",
"title": "A Phase 2 Study to Assess the Effect of BALSTILIMAB (AGEN2034) on Viral Clearance in HPV-positive Oropharyngeal Cancer Patients With Persistent HPV Detection in Plasma cfDNA After Definitive Therapy",
"has_exemption": false,
"start_date": "2023-10-18",
"completion_date": "2028-02-15",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06747585",
"publication_url": "https://clinicaltrials.gov/study/NCT06747585",
"title": "A Phase I/II, Open-Label, Multicenter Study of ALE.P02 (Claudin-1 Targeted Antibody-Drug Conjugate) as a Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+Squamous Solid Tumors",
"has_exemption": false,
"start_date": "2024-12-16",
"completion_date": "2028-02-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Alentis Therapeutics AG",
"sponsor_slug": "alentis-therapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948448",
"publication_url": "https://clinicaltrials.gov/study/NCT06948448",
"title": "A Randomized, Open Label, Multicenter, Phase 2 Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo® in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care for First-line Treatment of Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-11-18",
"completion_date": "2028-02-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Ono Pharmaceutical Co. Ltd",
"sponsor_slug": "ono-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07415031",
"publication_url": "https://clinicaltrials.gov/study/NCT07415031",
"title": "Solid Tumor Study for Long Term Treatment of Cancer Patients Who Have Participated in BMS Parent Studies Investigating Adagrasib (BMS-986503)",
"has_exemption": false,
"start_date": "2026-05-16",
"completion_date": "2028-02-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Mirati Therapeutics Inc.",
"sponsor_slug": "mirati-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05677971",
"publication_url": "https://clinicaltrials.gov/study/NCT05677971",
"title": "A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease With METAVIR Stage F2 to F4 Fibrosis",
"has_exemption": false,
"start_date": "2023-03-06",
"completion_date": "2028-02-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06706622",
"publication_url": "https://clinicaltrials.gov/study/NCT06706622",
"title": "Interventional, Randomized, Double-blind, Placebo-controlled, Optional Open-label Extension Trial of Lu AF82422 in Participants With Multiple System Atrophy",
"has_exemption": false,
"start_date": "2024-12-03",
"completion_date": "2028-02-17",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lundbeck A/S",
"sponsor_slug": "h-lundbeck-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06627244",
"publication_url": "https://clinicaltrials.gov/study/NCT06627244",
"title": "Phase 2, Single Arm Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2025-02-14",
"completion_date": "2028-02-17",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07007793",
"publication_url": "https://clinicaltrials.gov/study/NCT07007793",
"title": "A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Baxdrostat in Adult Participants With Primary Aldosteronism",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2028-02-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03850418",
"publication_url": "https://clinicaltrials.gov/study/NCT03850418",
"title": "Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant",
"has_exemption": false,
"start_date": "2019-07-01",
"completion_date": "2028-02-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Henry Ford Health System",
"sponsor_slug": "henry-ford-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06843434",
"publication_url": "https://clinicaltrials.gov/study/NCT06843434",
"title": "A Phase II Study of Neoadjuvant Botensilimab and Balstilimab Immunotherapy for Mismatch Repair Proficient Rectal Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-02-20",
"completion_date": "2028-02-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06439485",
"publication_url": "https://clinicaltrials.gov/study/NCT06439485",
"title": "Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2028-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07244263",
"publication_url": "https://clinicaltrials.gov/study/NCT07244263",
"title": "A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess Efficacy and Safety of Zasocitinib in Moderate to Severe Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2026-01-26",
"completion_date": "2028-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04083495",
"publication_url": "https://clinicaltrials.gov/study/NCT04083495",
"title": "Phase II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Relapsed/Refractory CD30+ Peripheral T Cell Lymphoma",
"has_exemption": false,
"start_date": "2019-09-17",
"completion_date": "2028-02-23",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06198712",
"publication_url": "https://clinicaltrials.gov/study/NCT06198712",
"title": "A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2023-01-12",
"completion_date": "2028-02-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Forma Therapeutics, Inc.",
"sponsor_slug": "forma-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06268873",
"publication_url": "https://clinicaltrials.gov/study/NCT06268873",
"title": "A Phase III, Randomised, Double-Blind Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on Chronic Kidney Disease (CKD) Progression in Participants With CKD and High Blood Pressure",
"has_exemption": false,
"start_date": "2024-03-29",
"completion_date": "2028-02-24",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06866405",
"publication_url": "https://clinicaltrials.gov/study/NCT06866405",
"title": "A Phase 3 Study to Investigate the Safety, Tolerability, and Immunogenicity of Revaccinating Pregnant Participants During Subsequent Pregnancies and Persistence of Immunity of a Single Dose of a Bivalent Respiratory Syncytial Virus (RSV) Vaccine.",
"has_exemption": false,
"start_date": "2025-04-16",
"completion_date": "2028-02-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06744920",
"publication_url": "https://clinicaltrials.gov/study/NCT06744920",
"title": "A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Remibrutinib in Patients With Generalized Myasthenia Gravis, Followed by an Open-label Extension Phase",
"has_exemption": false,
"start_date": "2025-02-07",
"completion_date": "2028-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06795022",
"publication_url": "https://clinicaltrials.gov/study/NCT06795022",
"title": "A Modular Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD9793, a T Cell-engaging Antibody Targeting Glypican-3 (GPC3) in Adult Participants With Advanced or Metastatic Solid Tumours (RHEA-1)",
"has_exemption": false,
"start_date": "2025-03-27",
"completion_date": "2028-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096908",
"publication_url": "https://clinicaltrials.gov/study/NCT07096908",
"title": "Treatment With Tirzepatide of the Disease of Obesity in People With Type 1 Diabetes",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2028-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Dasman Diabetes Institute",
"sponsor_slug": "dasman-diabetes-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02162849",
"publication_url": "https://clinicaltrials.gov/study/NCT02162849",
"title": "The Effects of Behavioral Counseling Plus Nicotine Replacement Therapy (NRT) or Varenicline on Smoking Cessation Among Smokers High and Low in Intrinsic Reward Sensitivity",
"has_exemption": false,
"start_date": "2015-12-14",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03074812",
"publication_url": "https://clinicaltrials.gov/study/NCT03074812",
"title": "Exploring Mechanisms for Neuropsychiatric Symptoms of Parkinson Disease Using Transcranial Direct Current Stimulation",
"has_exemption": false,
"start_date": "2016-02-29",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03438747",
"publication_url": "https://clinicaltrials.gov/study/NCT03438747",
"title": "An Assessment of P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation",
"has_exemption": false,
"start_date": "2018-04-24",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "CeraPedics, Inc",
"sponsor_slug": "cerapedics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03887715",
"publication_url": "https://clinicaltrials.gov/study/NCT03887715",
"title": "A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression",
"has_exemption": false,
"start_date": "2019-09-26",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "LivaNova",
"sponsor_slug": "livanova",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03282396",
"publication_url": "https://clinicaltrials.gov/study/NCT03282396",
"title": "Phase II Trial of Ibrutinib in Perviously Untreated High Risk Smoldering Mantle Cell Lymphoma (MCL)",
"has_exemption": false,
"start_date": "2020-06-08",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04610866",
"publication_url": "https://clinicaltrials.gov/study/NCT04610866",
"title": "Evaluation of the Safety,Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat",
"has_exemption": false,
"start_date": "2020-12-09",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04380545",
"publication_url": "https://clinicaltrials.gov/study/NCT04380545",
"title": "A Phase I/II Study of Nivolumab Plus 5-Fluorouracil Plus Interferon-α2b for Unresectable Fibrolamellar Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2021-01-13",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04931342",
"publication_url": "https://clinicaltrials.gov/study/NCT04931342",
"title": "A Phase II, Open-Label, Multicenter, Platform Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors",
"has_exemption": false,
"start_date": "2021-10-07",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04712539",
"publication_url": "https://clinicaltrials.gov/study/NCT04712539",
"title": "Efficacy of Combination Baloxovir and Oseltamivir Therapy in Influenza Infected Immunocompromised Hosts",
"has_exemption": false,
"start_date": "2021-10-11",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05037760",
"publication_url": "https://clinicaltrials.gov/study/NCT05037760",
"title": "A Phase 2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KER-050 as Monotherapy or in Combination With Ruxolitinib in Participants With Myelofibrosis",
"has_exemption": false,
"start_date": "2021-12-16",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05064280",
"publication_url": "https://clinicaltrials.gov/study/NCT05064280",
"title": "Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases",
"has_exemption": false,
"start_date": "2022-01-20",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04966481",
"publication_url": "https://clinicaltrials.gov/study/NCT04966481",
"title": "Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor: A Multicenter, Open-Label, Randomized Phase 3 Trial",
"has_exemption": false,
"start_date": "2022-04-06",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05594992",
"publication_url": "https://clinicaltrials.gov/study/NCT05594992",
"title": "An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in Mucopolysaccharidosis Type II (Hunter Syndrome) Subjects",
"has_exemption": false,
"start_date": "2023-02-22",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "JCR Pharmaceuticals Co., Ltd.",
"sponsor_slug": "jcr-pharmaceuticals-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05816382",
"publication_url": "https://clinicaltrials.gov/study/NCT05816382",
"title": "A Long-term Extension Study to Evaluate the Safety and Tolerability of TAK-861 in Participants With Selected Central Hypersomnia Conditions",
"has_exemption": false,
"start_date": "2023-04-05",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05546554",
"publication_url": "https://clinicaltrials.gov/study/NCT05546554",
"title": "Randomized Placebo-Controlled Crossover Trial of Suvorexant for Sleep in Children With Autism",
"has_exemption": false,
"start_date": "2023-08-09",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06331052",
"publication_url": "https://clinicaltrials.gov/study/NCT06331052",
"title": "3-D Tractography Focused Ultrasound Ablation for Essential Tremor",
"has_exemption": false,
"start_date": "2024-02-28",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06564038",
"publication_url": "https://clinicaltrials.gov/study/NCT06564038",
"title": "A Phase I/II Open-Label Multi-Centre Master Protocol to Evaluate the Safety and Efficacy of AZD0486 Monotherapy or in Combination With Other Anticancer Agents in Participants With Mature B-Cell Malignancies",
"has_exemption": false,
"start_date": "2025-01-30",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06964269",
"publication_url": "https://clinicaltrials.gov/study/NCT06964269",
"title": "A Phase 4 Pilot Study With Extension to Assess the Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease and the Effect on Corneal Nerves and Neuropathic Corneal Pain",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Toyos Clinic",
"sponsor_slug": "toyos-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06831149",
"publication_url": "https://clinicaltrials.gov/study/NCT06831149",
"title": "A Phase 2 Trial of Intraoperative Fluorescent Angiography to Decrease Pharyngocutaneous Fistula Rates in Patients Undergoing Hypopharyngeal Reconstruction",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Matthew Spector",
"sponsor_slug": "matthew-spector",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855498",
"publication_url": "https://clinicaltrials.gov/study/NCT06855498",
"title": "A Phase 3b, Multicenter, Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06810375",
"publication_url": "https://clinicaltrials.gov/study/NCT06810375",
"title": "Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "George Washington University",
"sponsor_slug": "george-washington-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06819670",
"publication_url": "https://clinicaltrials.gov/study/NCT06819670",
"title": "A Multicenter Pilot Clinical Trial to Prevent Infantile Spasms Relapse",
"has_exemption": false,
"start_date": "2025-05-05",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218679",
"publication_url": "https://clinicaltrials.gov/study/NCT07218679",
"title": "Clinical Trial on the Use of Stratafix Symmetric vs. Resorbable Monofilament for Closure of Large Median Laparotomy in Oncological Patients",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla",
"sponsor_slug": "fundacion-publica-andaluza-para-la-gestion-de-la-investigacion-en-sevilla",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06817018",
"publication_url": "https://clinicaltrials.gov/study/NCT06817018",
"title": "Ginger and the Microbiota-gut-brain Connection in Sciatic Pain Individuals",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Leslie Shen",
"sponsor_slug": "leslie-shen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07048262",
"publication_url": "https://clinicaltrials.gov/study/NCT07048262",
"title": "A Phase 2b, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose Range Finding Study to Evaluate the Efficacy, Safety, and Tolerability of Nebulized CSL787 in Adults (18 to 85 Years) With Non-cystic Fibrosis Bronchiectasis",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284875",
"publication_url": "https://clinicaltrials.gov/study/NCT07284875",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes",
"has_exemption": false,
"start_date": "2025-12-18",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Kailera",
"sponsor_slug": "kailera",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07287917",
"publication_url": "https://clinicaltrials.gov/study/NCT07287917",
"title": "A Phase 1b/2 Trial Investigating the Safety and Efficacy of Oral AMXT 1501 and Oral DFMO in Combination With Standard of Care in Patients With Advanced Solid Tumors Who Progressed After Prior Therapies",
"has_exemption": false,
"start_date": "2026-01-26",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Aminex Therapeutics, Inc.",
"sponsor_slug": "aminex-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06704100",
"publication_url": "https://clinicaltrials.gov/study/NCT06704100",
"title": "A Phase 2, Randomized, Double-blind, Placebo-controlled Trial of Fosamprenavir-Sodium Alginate Administered Orally for 8 Weeks to Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948084",
"publication_url": "https://clinicaltrials.gov/study/NCT06948084",
"title": "A Randomized Phase II Trial for High-Risk Multiple Myeloma That is Refractory or in First Relapse With Daratumumab, Teclistamab (DT) Versus Daratumumab, Pomalidomide, Dexamethasone (DPd) or Daratumumab, Carfilzomib, Dexamethasone (DKd)",
"has_exemption": false,
"start_date": "2026-04-29",
"completion_date": "2028-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02679144",
"publication_url": "https://clinicaltrials.gov/study/NCT02679144",
"title": "NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)",
"has_exemption": false,
"start_date": "2016-02-29",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03093116",
"publication_url": "https://clinicaltrials.gov/study/NCT03093116",
"title": "A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)",
"has_exemption": false,
"start_date": "2017-03-07",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Turning Point Therapeutics, Inc.",
"sponsor_slug": "turning-point-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04524611",
"publication_url": "https://clinicaltrials.gov/study/NCT04524611",
"title": "A Phase 3, Multicenter, Randomized, Efficacy Assessor-Blinded Study of Risankizumab Compared to Ustekinumab for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease Who Have Failed Anti-TNF Therapy",
"has_exemption": false,
"start_date": "2020-09-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04337580",
"publication_url": "https://clinicaltrials.gov/study/NCT04337580",
"title": "A Phase II Trial of FASN Inhibition by Omeprazole in Combination With Cabazitaxel in Patients With Docetaxel- and Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2021-03-05",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05130450",
"publication_url": "https://clinicaltrials.gov/study/NCT05130450",
"title": "An Open-Label Extension Study of AKCEA-APOCIII-LRx Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS)",
"has_exemption": false,
"start_date": "2021-11-18",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05215340",
"publication_url": "https://clinicaltrials.gov/study/NCT05215340",
"title": "A Randomized, Open-label, Phase 3 Trial of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in Treatment-naïve Subjects With Advanced or Metastatic PD-L1 High (TPS ≥50%) Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung08)",
"has_exemption": false,
"start_date": "2022-03-04",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04704505",
"publication_url": "https://clinicaltrials.gov/study/NCT04704505",
"title": "Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) (BAT-RAD Study)",
"has_exemption": false,
"start_date": "2022-04-28",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05456880",
"publication_url": "https://clinicaltrials.gov/study/NCT05456880",
"title": "A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients With Sickle Cell Disease and Severe Vaso-Occlusive Crises (Beacon Trial)",
"has_exemption": false,
"start_date": "2022-08-30",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Beam Therapeutics Inc.",
"sponsor_slug": "beam-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05529316",
"publication_url": "https://clinicaltrials.gov/study/NCT05529316",
"title": "A Multicohort, Open Label, Phase 2 Study of Botensilimab (AGEN1181) for Treatment of Advanced Melanoma Refractory to Prior Checkpoint Inhibitor Therapy",
"has_exemption": false,
"start_date": "2022-12-12",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Agenus Inc.",
"sponsor_slug": "agenus-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04905914",
"publication_url": "https://clinicaltrials.gov/study/NCT04905914",
"title": "A Phase 1/2a, Open-Label, Safety, Pharmacokinetic, And Preliminary Efficacy Study Of Oral ATRN-119 In Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2023-01-09",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Aprea Therapeutics",
"sponsor_slug": "aprea-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05783609",
"publication_url": "https://clinicaltrials.gov/study/NCT05783609",
"title": "A Phase 2 Study of Epcoritamab and Rituximab for First-line Treatment of Follicular Lymphoma",
"has_exemption": false,
"start_date": "2023-06-21",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Reid Merryman, MD",
"sponsor_slug": "reid-merryman-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05537896",
"publication_url": "https://clinicaltrials.gov/study/NCT05537896",
"title": "Prospective Evaluation of Xerava™ (Eravacycline) Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia",
"has_exemption": false,
"start_date": "2024-02-19",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "West Virginia University",
"sponsor_slug": "west-virginia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06260709",
"publication_url": "https://clinicaltrials.gov/study/NCT06260709",
"title": "Open-label Extension Study of Long-term Safety and Efficacy of NNC6019-0001 in Participants With Transthyretin Amyloid Cardiomyopathy (ATTR CM)",
"has_exemption": false,
"start_date": "2024-02-20",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06161025",
"publication_url": "https://clinicaltrials.gov/study/NCT06161025",
"title": "A Phase 2/3, Multicenter, Randomized Study of Raludotatug Deruxtecan (R-DXd), a CDH6-directed Antibody-drug Conjugate, in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer",
"has_exemption": false,
"start_date": "2024-02-27",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05913388",
"publication_url": "https://clinicaltrials.gov/study/NCT05913388",
"title": "Randomized Double-Blind Placebo Controlled Phase II Study of a Galectin-3 Inhibitor (GB1211) and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Providence Health & Services",
"sponsor_slug": "providence-health-services",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06191562",
"publication_url": "https://clinicaltrials.gov/study/NCT06191562",
"title": "Randomized Clinical Trial of Post-operative Outcomes Following Posterior Versus Anterior Tympanostomy Tube Placement",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2028-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "David Chi, MD",
"sponsor_slug": "david-chi-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}